Bevacizumab treatment in the elderly patient with metastatic colorectal cancer

Overview of attention for article published in Clinical Interventions in Aging, January 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent: 8 patents

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Dove Medical Press

Article Metrics

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer

About this Attention Score

Mentioned by

Citations

Readers on

Dove Medical Press

Article Metrics

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer

About this Attention Score

Mentioned by

Citations

Readers on

Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4

Grant US-11840571-B2

United States of America

Variant CD3-binding domains and their use in combination therapies for the treatment of…

Grant US-11685781-B2

United States of America

PD-1-binding molecules and methods of use thereof

Grant US-11623959-B2

United States of America

PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF

Application EP-3981792-A1

European Patent Office

Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use…

Grant US-10954301-B2

United States of America

PD-1-binding molecules and methods of use thereof

Grant US-10577422-B2

United States of America

PD-1 AND LAG-3 BINDING MOLECULES AND METHODS OF USE THEREOF

Application EP-3456346-A1

European Patent Office

PD-1-BINDING MOLECULES AND METHODS USE THEREOF

Application WO-2017019846-A1

World Intellectual Property Organisation (WIPO)